Global and China Non-opioid Pain Patches Market Insights, Forecast to 2026

Global and China Non-opioid Pain Patches Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Non-opioid Pain Patches Product Introduction
1.2 Market Segments
1.3 Key Non-opioid Pain Patches Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Non-opioid Pain Patches Market Size Growth Rate by Type
1.4.2 Lidocaine Patch
1.4.3 Diclofenac Patch
1.4.4 Methyl Salicylate Patch
1.4.5 Capsaicin Patch
1.4.6 Ketoprofen Patch
1.4.7 Other
1.5 Market by Application
1.5.1 Global Non-opioid Pain Patches Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Independent Pharmacies & Drug Stores
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Non-opioid Pain Patches Market Size, Estimates and Forecasts
2.1.1 Global Non-opioid Pain Patches Revenue 2015-2026
2.1.2 Global Non-opioid Pain Patches Sales 2015-2026
2.2 Global Non-opioid Pain Patches, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Non-opioid Pain Patches Historical Market Size by Region (2015-2020)
2.3.1 Global Non-opioid Pain Patches Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Non-opioid Pain Patches Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Non-opioid Pain Patches Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Non-opioid Pain Patches Sales Forecast by Region (2021-2026)
2.4.2 Global Non-opioid Pain Patches Revenue Forecast by Region (2021-2026)
3 Global Non-opioid Pain Patches Competitor Landscape by Players
3.1 Global Top Non-opioid Pain Patches Sales by Manufacturers
3.1.1 Global Non-opioid Pain Patches Sales by Manufacturers (2015-2020)
3.1.2 Global Non-opioid Pain Patches Sales Market Share by Manufacturers (2015-2020)
3.2 Global Non-opioid Pain Patches Manufacturers by Revenue
3.2.1 Global Non-opioid Pain Patches Revenue by Manufacturers (2015-2020)
3.2.2 Global Non-opioid Pain Patches Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Non-opioid Pain Patches Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Non-opioid Pain Patches Revenue in 2019
3.2.5 Global Non-opioid Pain Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Non-opioid Pain Patches Price by Manufacturers
3.4 Global Non-opioid Pain Patches Manufacturing Base Distribution, Product Types
3.4.1 Non-opioid Pain Patches Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Non-opioid Pain Patches Product Type
3.4.3 Date of International Manufacturers Enter into Non-opioid Pain Patches Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Non-opioid Pain Patches Market Size by Type (2015-2020)
4.1.1 Global Non-opioid Pain Patches Sales by Type (2015-2020)
4.1.2 Global Non-opioid Pain Patches Revenue by Type (2015-2020)
4.1.3 Non-opioid Pain Patches Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Non-opioid Pain Patches Market Size Forecast by Type (2021-2026)
4.2.1 Global Non-opioid Pain Patches Sales Forecast by Type (2021-2026)
4.2.2 Global Non-opioid Pain Patches Revenue Forecast by Type (2021-2026)
4.2.3 Non-opioid Pain Patches Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Non-opioid Pain Patches Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Non-opioid Pain Patches Market Size by Application (2015-2020)
5.1.1 Global Non-opioid Pain Patches Sales by Application (2015-2020)
5.1.2 Global Non-opioid Pain Patches Revenue by Application (2015-2020)
5.1.3 Non-opioid Pain Patches Price by Application (2015-2020)
5.2 Non-opioid Pain Patches Market Size Forecast by Application (2021-2026)
5.2.1 Global Non-opioid Pain Patches Sales Forecast by Application (2021-2026)
5.2.2 Global Non-opioid Pain Patches Revenue Forecast by Application (2021-2026)
5.2.3 Global Non-opioid Pain Patches Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Non-opioid Pain Patches Market Size YoY Growth 2015-2026
6.1.1 China Non-opioid Pain Patches Sales YoY Growth 2015-2026
6.1.2 China Non-opioid Pain Patches Revenue YoY Growth 2015-2026
6.1.3 China Non-opioid Pain Patches Market Share in Global Market 2015-2026
6.2 China Non-opioid Pain Patches Market Size by Players (International and Local Players)
6.2.1 China Top Non-opioid Pain Patches Players by Sales (2015-2020)
6.2.2 China Top Non-opioid Pain Patches Players by Revenue (2015-2020)
6.3 China Non-opioid Pain Patches Historic Market Review by Type (2015-2020)
6.3.1 China Non-opioid Pain Patches Sales Market Share by Type (2015-2020)
6.3.2 China Non-opioid Pain Patches Revenue Market Share by Type (2015-2020)
6.3.3 China Non-opioid Pain Patches Price by Type (2015-2020)
6.4 China Non-opioid Pain Patches Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Non-opioid Pain Patches Sales Forecast by Type (2021-2026)
6.4.2 China Non-opioid Pain Patches Revenue Forecast by Type (2021-2026)
6.4.3 China Non-opioid Pain Patches Price Forecast by Type (2021-2026)
6.5 China Non-opioid Pain Patches Historic Market Review by Application (2015-2020)
6.5.1 China Non-opioid Pain Patches Sales Market Share by Application (2015-2020)
6.5.2 China Non-opioid Pain Patches Revenue Market Share by Application (2015-2020)
6.5.3 China Non-opioid Pain Patches Price by Application (2015-2020)
6.6 China Non-opioid Pain Patches Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Non-opioid Pain Patches Sales Forecast by Application (2021-2026)
6.6.2 China Non-opioid Pain Patches Revenue Forecast by Application (2021-2026)
6.6.3 China Non-opioid Pain Patches Price Forecast by Application (2021-2026)
7 North America
7.1 North America Non-opioid Pain Patches Market Size YoY Growth 2015-2026
7.2 North America Non-opioid Pain Patches Market Facts & Figures by Country
7.2.1 North America Non-opioid Pain Patches Sales by Country (2015-2020)
7.2.2 North America Non-opioid Pain Patches Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Non-opioid Pain Patches Market Size YoY Growth 2015-2026
8.2 Europe Non-opioid Pain Patches Market Facts & Figures by Country
8.2.1 Europe Non-opioid Pain Patches Sales by Country
8.2.2 Europe Non-opioid Pain Patches Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Non-opioid Pain Patches Market Size YoY Growth 2015-2026
9.2 Asia Pacific Non-opioid Pain Patches Market Facts & Figures by Country
9.2.1 Asia Pacific Non-opioid Pain Patches Sales by Region (2015-2020)
9.2.2 Asia Pacific Non-opioid Pain Patches Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Non-opioid Pain Patches Market Size YoY Growth 2015-2026
10.2 Latin America Non-opioid Pain Patches Market Facts & Figures by Country
10.2.1 Latin America Non-opioid Pain Patches Sales by Country
10.2.2 Latin America Non-opioid Pain Patches Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Non-opioid Pain Patches Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Non-opioid Pain Patches Market Facts & Figures by Country
11.2.1 Middle East and Africa Non-opioid Pain Patches Sales by Country
11.2.2 Middle East and Africa Non-opioid Pain Patches Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Non-opioid Pain Patches Products Offered
12.1.5 Pfizer Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Corporation Information
12.2.2 GlaxoSmithKline Description and Business Overview
12.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GlaxoSmithKline Non-opioid Pain Patches Products Offered
12.2.5 GlaxoSmithKline Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Corporation Information
12.3.2 Johnson & Johnson Description and Business Overview
12.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Johnson & Johnson Non-opioid Pain Patches Products Offered
12.3.5 Johnson & Johnson Recent Development
12.4 Novartis AG
12.4.1 Novartis AG Corporation Information
12.4.2 Novartis AG Description and Business Overview
12.4.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Novartis AG Non-opioid Pain Patches Products Offered
12.4.5 Novartis AG Recent Development
12.5 Mylan N.V.
12.5.1 Mylan N.V. Corporation Information
12.5.2 Mylan N.V. Description and Business Overview
12.5.3 Mylan N.V. Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Mylan N.V. Non-opioid Pain Patches Products Offered
12.5.5 Mylan N.V. Recent Development
12.6 Teva Pharmaceutical Industries
12.6.1 Teva Pharmaceutical Industries Corporation Information
12.6.2 Teva Pharmaceutical Industries Description and Business Overview
12.6.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Teva Pharmaceutical Industries Non-opioid Pain Patches Products Offered
12.6.5 Teva Pharmaceutical Industries Recent Development
12.7 Hisamitsu Pharmaceutical
12.7.1 Hisamitsu Pharmaceutical Corporation Information
12.7.2 Hisamitsu Pharmaceutical Description and Business Overview
12.7.3 Hisamitsu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Hisamitsu Pharmaceutical Non-opioid Pain Patches Products Offered
12.7.5 Hisamitsu Pharmaceutical Recent Development
12.8 TEH SENG Pharmaceutical
12.8.1 TEH SENG Pharmaceutical Corporation Information
12.8.2 TEH SENG Pharmaceutical Description and Business Overview
12.8.3 TEH SENG Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.8.4 TEH SENG Pharmaceutical Non-opioid Pain Patches Products Offered
12.8.5 TEH SENG Pharmaceutical Recent Development
12.9 Teikoku Seiyaku
12.9.1 Teikoku Seiyaku Corporation Information
12.9.2 Teikoku Seiyaku Description and Business Overview
12.9.3 Teikoku Seiyaku Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Teikoku Seiyaku Non-opioid Pain Patches Products Offered
12.9.5 Teikoku Seiyaku Recent Development
12.10 IBSA Institut Biochimque SA
12.10.1 IBSA Institut Biochimque SA Corporation Information
12.10.2 IBSA Institut Biochimque SA Description and Business Overview
12.10.3 IBSA Institut Biochimque SA Sales, Revenue and Gross Margin (2015-2020)
12.10.4 IBSA Institut Biochimque SA Non-opioid Pain Patches Products Offered
12.10.5 IBSA Institut Biochimque SA Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Pfizer Non-opioid Pain Patches Products Offered
12.11.5 Pfizer Recent Development
12.12 Allergan PLC
12.12.1 Allergan PLC Corporation Information
12.12.2 Allergan PLC Description and Business Overview
12.12.3 Allergan PLC Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Allergan PLC Products Offered
12.12.5 Allergan PLC Recent Development
12.13 Endo International
12.13.1 Endo International Corporation Information
12.13.2 Endo International Description and Business Overview
12.13.3 Endo International Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Endo International Products Offered
12.13.5 Endo International Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Non-opioid Pain Patches Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Non-opioid Pain Patches Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Non-opioid Pain Patches Market Segments
Table 2. Ranking of Global Top Non-opioid Pain Patches Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Non-opioid Pain Patches Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Lidocaine Patch
Table 5. Major Manufacturers of Diclofenac Patch
Table 6. Major Manufacturers of Methyl Salicylate Patch
Table 7. Major Manufacturers of Capsaicin Patch
Table 8. Major Manufacturers of Ketoprofen Patch
Table 9. Major Manufacturers of Other
Table 10. Global Non-opioid Pain Patches Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Non-opioid Pain Patches Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Non-opioid Pain Patches Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Non-opioid Pain Patches Sales Market Share by Regions (2015-2020)
Table 14. Global Non-opioid Pain Patches Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Non-opioid Pain Patches Sales Forecast by Region (2021-2026) (K Pcs)
Table 16. Global Non-opioid Pain Patches Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Non-opioid Pain Patches Sales Share by Manufacturers (2015-2020)
Table 18. Global Non-opioid Pain Patches Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Non-opioid Pain Patches by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-opioid Pain Patches as of 2019)
Table 20. Non-opioid Pain Patches Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Non-opioid Pain Patches Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Non-opioid Pain Patches Price (2015-2020) (USD/Pcs)
Table 23. Non-opioid Pain Patches Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Non-opioid Pain Patches Product Type
Table 25. Date of International Manufacturers Enter into Non-opioid Pain Patches Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Non-opioid Pain Patches Sales by Type (2015-2020) (K Pcs)
Table 28. Global Non-opioid Pain Patches Sales Share by Type (2015-2020)
Table 29. Global Non-opioid Pain Patches Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Non-opioid Pain Patches Revenue Share by Type (2015-2020)
Table 31. Non-opioid Pain Patches Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Non-opioid Pain Patches Sales Share by Type (2021-2026)
Table 33. Global Non-opioid Pain Patches Sales by Application (2015-2020) (K Pcs)
Table 34. Global Non-opioid Pain Patches Sales Share by Application (2015-2020)
Table 35. Global Non-opioid Pain Patches Sales Share by Application (2021-2026)
Table 36. Global Non-opioid Pain Patches Sales Market Share Forecast by Application (2021-2026)
Table 37. Global Non-opioid Pain Patches Revenue by Application (2015-2020) (US$ Million)
Table 38. Global Non-opioid Pain Patches Revenue Market Share Forecast by Application (2021-2026)
Table 39. China Non-opioid Pain Patches Sales (K Pcs) of Key Companies (2015-2020)
Table 40. China Non-opioid Pain Patches Sales Share by Company (2015-2020)
Table 41. China Non-opioid Pain Patches Revenue (US$ Million) by Company (2015-2020)
Table 42. China Non-opioid Pain Patches Sales (K Pcs) by Type (2015-2020)
Table 43. China Non-opioid Pain Patches Sales Share by Type (2015-2020)
Table 44. China Non-opioid Pain Patches Revenue (US$ Million) Market Share by Type (2015-2020)
Table 45. China Non-opioid Pain Patches Price (K Pcs) by Type (2015-2020)
Table 46. China Non-opioid Pain Patches Sales (K Pcs) by Type (2021-2026)
Table 47. China Non-opioid Pain Patches Sales Share by Type (2021-2026)
Table 48. China Non-opioid Pain Patches Revenue (US$ Million) Market Share by Type (2021-2026)
Table 49. China Non-opioid Pain Patches Revenue Share by Type (2021-2026)
Table 50. China Non-opioid Pain Patches Price (K Pcs) by Type (2021-2026)
Table 51. China Non-opioid Pain Patches Sales (K Pcs) by Application (2015-2020)
Table 52. China Non-opioid Pain Patches Sales Share by Application (2015-2020)
Table 53. China Non-opioid Pain Patches Revenue (US$ Million) Market Share by Application (2015-2020)
Table 54. China Non-opioid Pain Patches Sales (K Pcs) by Application (2021-2026)
Table 55. China Non-opioid Pain Patches Sales Share by Application (2021-2026)
Table 56. China Non-opioid Pain Patches Revenue (US$ Million) Market Share by Application (2021-2026)
Table 57. China Non-opioid Pain Patches Revenue Share by Application (2021-2026)
Table 58. North America Non-opioid Pain Patches Sales by Country (2015-2020) (K Pcs)
Table 59. North America Non-opioid Pain Patches Sales Market Share by Country (2015-2020)
Table 60. North America Non-opioid Pain Patches Revenue by Country (2015-2020) (US$ Million)
Table 61. North America Non-opioid Pain Patches Revenue Market Share by Country (2015-2020)
Table 62. Europe Non-opioid Pain Patches Sales by Country (2015-2020) (K Pcs)
Table 63. Europe Non-opioid Pain Patches Sales Market Share by Country (2015-2020)
Table 64. Europe Non-opioid Pain Patches Revenue by Country (2015-2020) (US$ Million)
Table 65. Europe Non-opioid Pain Patches Revenue Market Share by Country (2015-2020)
Table 66. Asia Pacific Non-opioid Pain Patches Sales by Region (2015-2020) (K Pcs)
Table 67. Asia Pacific Non-opioid Pain Patches Sales Market Share by Region (2015-2020)
Table 68. Asia Pacific Non-opioid Pain Patches Revenue by Region (2015-2020) (US$ Million)
Table 69. Asia Pacific Non-opioid Pain Patches Revenue Market Share by Region (2015-2020)
Table 70. Latin America Non-opioid Pain Patches Sales by Country (2015-2020) (K Pcs)
Table 71. Latin America Non-opioid Pain Patches Sales Market Share by Country (2015-2020)
Table 72. Latin Americaa Non-opioid Pain Patches Revenue by Country (2015-2020) (US$ Million)
Table 73. Latin America Non-opioid Pain Patches Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Non-opioid Pain Patches Sales by Country (2015-2020) (K Pcs)
Table 75. Middle East and Africa Non-opioid Pain Patches Sales Market Share by Country (2015-2020)
Table 76. Middle East and Africa Non-opioid Pain Patches Revenue by Country (2015-2020) (US$ Million)
Table 77. Middle East and Africa Non-opioid Pain Patches Revenue Market Share by Country (2015-2020)
Table 78. Pfizer Corporation Information
Table 79. Pfizer Description and Business Overview
Table 80. Pfizer Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Pfizer Non-opioid Pain Patches Product
Table 82. Pfizer Recent Development
Table 83. GlaxoSmithKline Corporation Information
Table 84. GlaxoSmithKline Description and Business Overview
Table 85. GlaxoSmithKline Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. GlaxoSmithKline Product
Table 87. GlaxoSmithKline Recent Development
Table 88. Johnson & Johnson Corporation Information
Table 89. Johnson & Johnson Description and Business Overview
Table 90. Johnson & Johnson Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Johnson & Johnson Product
Table 92. Johnson & Johnson Recent Development
Table 93. Novartis AG Corporation Information
Table 94. Novartis AG Description and Business Overview
Table 95. Novartis AG Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Novartis AG Product
Table 97. Novartis AG Recent Development
Table 98. Mylan N.V. Corporation Information
Table 99. Mylan N.V. Description and Business Overview
Table 100. Mylan N.V. Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Mylan N.V. Product
Table 102. Mylan N.V. Recent Development
Table 103. Teva Pharmaceutical Industries Corporation Information
Table 104. Teva Pharmaceutical Industries Description and Business Overview
Table 105. Teva Pharmaceutical Industries Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Teva Pharmaceutical Industries Product
Table 107. Teva Pharmaceutical Industries Recent Development
Table 108. Hisamitsu Pharmaceutical Corporation Information
Table 109. Hisamitsu Pharmaceutical Description and Business Overview
Table 110. Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Hisamitsu Pharmaceutical Product
Table 112. Hisamitsu Pharmaceutical Recent Development
Table 113. TEH SENG Pharmaceutical Corporation Information
Table 114. TEH SENG Pharmaceutical Description and Business Overview
Table 115. TEH SENG Pharmaceutical Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. TEH SENG Pharmaceutical Product
Table 117. TEH SENG Pharmaceutical Recent Development
Table 118. Teikoku Seiyaku Corporation Information
Table 119. Teikoku Seiyaku Description and Business Overview
Table 120. Teikoku Seiyaku Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. Teikoku Seiyaku Product
Table 122. Teikoku Seiyaku Recent Development
Table 123. IBSA Institut Biochimque SA Corporation Information
Table 124. IBSA Institut Biochimque SA Description and Business Overview
Table 125. IBSA Institut Biochimque SA Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 126. IBSA Institut Biochimque SA Product
Table 127. IBSA Institut Biochimque SA Recent Development
Table 128. Acorda Therapeutics Corporation Information
Table 129. Acorda Therapeutics Description and Business Overview
Table 130. Acorda Therapeutics Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 131. Acorda Therapeutics Product
Table 132. Acorda Therapeutics Recent Development
Table 133. Allergan PLC Corporation Information
Table 134. Allergan PLC Description and Business Overview
Table 135. Allergan PLC Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 136. Allergan PLC Product
Table 137. Allergan PLC Recent Development
Table 138. Endo International Corporation Information
Table 139. Endo International Description and Business Overview
Table 140. Endo International Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 141. Endo International Product
Table 142. Endo International Recent Development
Table 143. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 144. Key Challenges
Table 145. Market Risks
Table 146. Main Points Interviewed from Key Non-opioid Pain Patches Players
Table 147. Non-opioid Pain Patches Customers List
Table 148. Non-opioid Pain Patches Distributors List
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-opioid Pain Patches Product Picture
Figure 2. Global Non-opioid Pain Patches Sales Market Share by Type in 2020 & 2026
Figure 3. Lidocaine Patch Product Picture
Figure 4. Diclofenac Patch Product Picture
Figure 5. Methyl Salicylate Patch Product Picture
Figure 6. Capsaicin Patch Product Picture
Figure 7. Ketoprofen Patch Product Picture
Figure 8. Other Product Picture
Figure 9. Global Non-opioid Pain Patches Sales Market Share by Application in 2020 & 2026
Figure 10. Hospital Pharmacies
Figure 11. Independent Pharmacies & Drug Stores
Figure 12. Online Pharmacies
Figure 13. Non-opioid Pain Patches Report Years Considered
Figure 14. Global Non-opioid Pain Patches Market Size 2015-2026 (US$ Million)
Figure 15. Global Non-opioid Pain Patches Sales 2015-2026 (K Pcs)
Figure 16. Global Non-opioid Pain Patches Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Non-opioid Pain Patches Sales Market Share by Region (2015-2020)
Figure 18. Global Non-opioid Pain Patches Sales Market Share by Region in 2019
Figure 19. Global Non-opioid Pain Patches Revenue Market Share by Region (2015-2020)
Figure 20. Global Non-opioid Pain Patches Revenue Market Share by Region in 2019
Figure 21. Global Non-opioid Pain Patches Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Non-opioid Pain Patches Revenue in 2019
Figure 23. Non-opioid Pain Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Non-opioid Pain Patches Sales Market Share by Type (2015-2020)
Figure 25. Global Non-opioid Pain Patches Sales Market Share by Type in 2019
Figure 26. Global Non-opioid Pain Patches Revenue Market Share by Type (2015-2020)
Figure 27. Global Non-opioid Pain Patches Revenue Market Share by Type in 2019
Figure 28. Global Non-opioid Pain Patches Market Share by Price Range (2015-2020)
Figure 29. Global Non-opioid Pain Patches Sales Market Share by Application (2015-2020)
Figure 30. Global Non-opioid Pain Patches Sales Market Share by Application in 2019
Figure 31. Global Non-opioid Pain Patches Revenue Market Share by Application (2015-2020)
Figure 32. Global Non-opioid Pain Patches Revenue Market Share by Application in 2019
Figure 33. China Non-opioid Pain Patches Sales Growth Rate 2015-2026 (K Pcs)
Figure 34. China Non-opioid Pain Patches Revenue Growth Rate 2015-2026 (US$ Million)
Figure 35. China Non-opioid Pain Patches Market Share in Global Market 2015-2026
Figure 36. China 5 and 10 Largest Non-opioid Pain Patches Players Market Share by Revenue in Non-opioid Pain Patches in 2019
Figure 37. China Non-opioid Pain Patches Revenue Share by Type (2015-2020)
Figure 38. China Non-opioid Pain Patches Revenue Growth Rate by Type in 2015 & 2019
Figure 39. China Non-opioid Pain Patches Revenue Share by Application (2015-2020)
Figure 40. China Non-opioid Pain Patches Revenue Growth Rate by Application in 2015 & 2019
Figure 41. North America Non-opioid Pain Patches Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. North America Non-opioid Pain Patches Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. North America Non-opioid Pain Patches Sales Market Share by Country in 2019
Figure 44. North America Non-opioid Pain Patches Revenue Market Share by Country in 2019
Figure 45. U.S. Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. U.S. Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Canada Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Canada Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Europe Non-opioid Pain Patches Sales Growth Rate 2015-2020 (K Pcs)
Figure 50. Europe Non-opioid Pain Patches Revenue Growth Rate 2015-2020 (US$ Million)
Figure 51. Europe Non-opioid Pain Patches Sales Market Share by Country in 2019
Figure 52. Europe Non-opioid Pain Patches Revenue Market Share by Country in 2019
Figure 53. Germany Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Germany Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. France Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. France Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. U.K. Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. U.K. Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Italy Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. Italy Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Russia Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Asia Pacific Non-opioid Pain Patches Sales Growth Rate 2015-2020 (K Pcs)
Figure 64. Asia Pacific Non-opioid Pain Patches Revenue Growth Rate 2015-2020 (US$ Million)
Figure 65. Asia Pacific Non-opioid Pain Patches Sales Market Share by Region in 2019
Figure 66. Asia Pacific Non-opioid Pain Patches Revenue Market Share by Region in 2019
Figure 67. China Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. China Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Japan Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Japan Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. South Korea Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. South Korea Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. India Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. India Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Australia Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Australia Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Taiwan Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Taiwan Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Indonesia Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Indonesia Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Thailand Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Thailand Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Malaysia Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Malaysia Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Philippines Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Philippines Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Vietnam Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 88. Vietnam Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Latin America Non-opioid Pain Patches Sales Growth Rate 2015-2020 (K Pcs)
Figure 90. Latin America Non-opioid Pain Patches Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Non-opioid Pain Patches Sales Market Share by Country in 2019
Figure 92. Latin America Non-opioid Pain Patches Revenue Market Share by Country in 2019
Figure 93. Mexico Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Mexico Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Brazil Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 98. Argentina Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Middle East and Africa Non-opioid Pain Patches Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Non-opioid Pain Patches Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Non-opioid Pain Patches Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Non-opioid Pain Patches Revenue Market Share by Country in 2019
Figure 103. Turkey Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 108.

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs